Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip. (April 2019) - Bessette, L.; Schnitzer, T.; Khan, A.; Pixton, G.; Viktrup, L.; Davignon, I.; Tive, L.; Brown, M.; West, C.